Original Literature | Model OverView |
---|---|
Publication
Title
Origin and physiological roles of inflammation.
Affiliation
Howard Hughes Medical Institute and Department of Immunobiology, Yale UniversitySchool of Medicine, TAC S-669, 300 Cedar Street, New Haven, Connecticut 06510,USA. ruslan.medzhitov@yale.edu
Abstract
Inflammation underlies a wide variety of physiological and pathologicalprocesses. Although the pathological aspects of many types of inflammation arewell appreciated, their physiological functions are mostly unknown. The classicinstigators of inflammation - infection and tissue injury - are at one end of alarge range of adverse conditions that induce inflammation, and they trigger therecruitment of leukocytes and plasma proteins to the affected tissue site.Tissue stress or malfunction similarly induces an adaptive response, which isreferred to here as para-inflammation. This response relies mainly ontissue-resident macrophages and is intermediate between the basal homeostaticstate and a classic inflammatory response. Para-inflammation is probablyresponsible for the chronic inflammatory conditions that are associated withmodern human diseases.
PMID
18650913
|
Entity
arachidonic acid
--
MO000000310
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m349736
10
infinite
0
TRANSPATH | MO000000310 |
--
coagulation factor XII
--
MO000004852
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m574
10
infinite
0
TRANSPATH | MO000004852 |
--
Caspase-1
--
MO000016828
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1765
10
infinite
0
TRANSPATH | MO000016828 |
--
Caspase-6
--
MO000017602
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2381
10
infinite
0
TRANSPATH | MO000017602 |
--
Caspase-7
--
MO000017603
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2382
10
infinite
0
TRANSPATH | MO000017603 |
--
PARP
--
MO000018318
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2965
10
infinite
0
InterPro | IPR008288 |
TRANSPATH | MO000018318 |
--
thromboxane A2
--
MO000018986
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m3594
10
infinite
0
TRANSPATH | MO000018986 |
--
elastase
--
MO000019242
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3826
10
infinite
0
TRANSPATH | MO000019242 |
--
protein remnants
--
MO000019479
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m360980
10
infinite
0
TRANSPATH | MO000019479 |
--
lipoxygenase
--
MO000021434
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m5784
10
infinite
0
TRANSPATH | MO000021434 |
--
prostaglandins
--
MO000021832
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m6166
10
infinite
0
Ensembl | ENSG00000035862 |
TRANSPATH | MO000021832 |
--
leukotrienes
--
MO000033520
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m12196
10
infinite
0
TRANSPATH | MO000033520 |
--
cathepsin L
--
MO000060672
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m35573
10
infinite
0
TRANSPATH | MO000060672 |
--
RAGE
--
MO000069310
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m44154
10
infinite
0
TRANSPATH | MO000069310 |
--
collagen
--
MO000083632
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m57739
10
infinite
0
TRANSPATH | MO000083632 |
--
phosphatidylcholine
--
MO000102990
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m75937
10
infinite
0
TRANSPATH | MO000102990 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
NALP3
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
pore forming exotoxin
--
e12
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m12
0
infinite
0
--
pore forming exotoxin: NALP3
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m13
0
infinite
0
--
ATP
--
e14
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
P2X7
--
e15
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m15
0
infinite
0
--
P2X7: ATP
--
e16
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m16
0
infinite
0
--
K+
--
e17
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
K+
--
e18
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
pore forming exotoxin: NALP3{activated}
--
e19
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
nociceptors
--
e20
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m20
0
infinite
0
--
nociceptors {activated}
--
e21
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m21
0
infinite
0
--
S100A12: RAGE
--
e22
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m22
0
infinite
0
--
HMGB1{intracellular}
--
e23
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m23
10
infinite
0
TRANSPATH | MO000044940 |
--
HMGB1: RAGE
--
e24
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m24
0
infinite
0
--
coagulation factor XII{activated}
--
e25
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m25
10
infinite
0
TRANSPATH | MO000004852 |
--
serotonin
--
e27
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m27
0
infinite
0
--
NALP3{activated}
--
e28
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m28
0
infinite
0
--
AGEs
--
e29
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
AGEs: RAGE
--
e30
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m30
0
infinite
0
--
AGEs{intracellular}
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
kinin{activated}
--
e33
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
kinin
--
e34
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
Ca2+
--
e35
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
csml-variable:Double
m36
10
infinite
0
Affymetrix | 130062_f_at |
Ensembl | ENSMUSG00000029522 |
MGD | Pla2g1b |
Proteome | HumanPSD/Pla2g1b |
RefSeq | NM_011107 |
TRANSPATH | MO000096856 |
Unigene | Mm.20190 |
UniProt | Q9Z0Y2 |
--
phospholipase A2{activated}
--
e37
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m37
10
infinite
0
Affymetrix | 130062_f_at |
Ensembl | ENSMUSG00000029522 |
MGD | Pla2g1b |
Proteome | HumanPSD/Pla2g1b |
RefSeq | NM_011107 |
TRANSPATH | MO000096856 |
Unigene | Mm.20190 |
UniProt | Q9Z0Y2 |
--
lysophosphatidic acid
--
e38
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
lipoxins
--
e39
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
platelate activating factor
--
e40
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m40
0
infinite
0
--
basement-membrane protein
--
e41
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
csml-variable:Double
m43
0
infinite
0
--
kallikrein{activated}
--
e5
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
kallikrein
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c49 : 1
stoichiometry:c48 : 1
m6*m25*0.1
nodelay
--
0
PMID: 18650913 The Hageman factor activates the kallikrein?kinin cascade, and the main product of this cascade, bradykinin, affects the vasculature, as well as having a potent pro-algesic (pain-stimulating) effect.
p10
p10
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c21 : 1
stoichiometry:c22 : 1
m22603*m44154*0.1
nodelay
--
0
PMID: 18650913, 16267105, 10399917 HMGB1 and S100A12 engage the receptor RAGE (advanced glycation end-product-specific receptor; also known as AGER), which (atleast in the case of HMGB1) cooperates with TLRs to induce aninflammatory response.
p11
p11
cso30:i:ME_Translocation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c25 : 1
stoichiometry:c24 : 1
m23*m155666*0.1
nodelay
--
0
PMID: 18650913, 15331624 The prime example in this case is HMGB1, which has been shown to be secreted by macrophages stimulated with the TLR4 ligand lipopolysaccharide, apparently in the absence of necrotic cell death, suggesting that the non-canonical caspase-1-dependent secretory pathway might be involved.
p12
p12
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c28 : 1
stoichiometry:c27 : 1
m574*m57739*0.1
nodelay
--
0
PMID: 18650913 A key plasma-derived regulator of inflammation, the Hageman factor (also known as factor XII), becomes activated by contact with collagen and other components of the extracellular matrix (ECM).
p13
p13
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c33 : 1
stoichiometry:c29 : 1
m95345*m57739*0.1
nodelay
--
0
PMID: 18650913 Platelets are also activated by contact with collagen and produce various inflammatory mediators, including thromboxanes and serotonin.
p14
p14
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c34 : 1
stoichiometry:c32 : 1
m27*m57739*0.1
nodelay
--
0
PMID: 18650913 Platelets are also activated by contact with collagen and produce various inflammatory mediators, including thromboxanes and serotonin.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m11*0.1
nodelay
--
0
PMID: 18650913, 18403674, 16407889 Phagocytosis of these particles triggers the activation of the NALP3 inflammasome and subsequently the production of caspase-1 substrates, including members of the interleukin 1 (IL-1) family.
p16
p16
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c39 : 1
stoichiometry:c38 : 1
m93364*m28*0.1
nodelay
--
0
PMID: 18650913, 18403674, 16407889 Phagocytosis of these particles triggers the activation of the NALP3 inflammasome and subsequently the production of caspase-1 substrates, including members of the interleukin 1 (IL-1) family.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m44154*m29*0.1
nodelay
--
0
PMID: 18650913, 10399917, 17425919 In addition, AGEs are recognized by their receptor, RAGE, which has inflammatory activity either alone21 or in combination with TLRs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m31*0.1
nodelay
--
0
PMID: 18650913, 3283558 AGEs are products of the non-enzymatic glycation of long-lived proteins, such as collagen.
p19
p19
cso30:i:ME_Translocation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m32*0.1
nodelay
--
0
PMID: 18650913, 3283558 AGEs are products of the non-enzymatic glycation of long-lived proteins, such as collagen.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c52 : 1
stoichiometry:c51 : 1
m34*m5*0.1
nodelay
--
0
PMID: 18650913 The Hageman factor activates the kallikrein?kinin cascade, and the main product of this cascade, bradykinin, affects the vasculature, as well as having a potent pro-algesic (pain-stimulating) effect.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m35*m36*0.1
nodelay
--
0
PMID: 18650913 After activation by intracellular Ca2+ ions, cytosolic phospholipase A2 generates arachidonic acid and lysophosphatidic acid, the precursors of the two classes of lipid mediator listed above, from phosphatidylcholine.
p21
p21
cso30:i:ME_UnknownProduction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c62 : 1
stoichiometry:c60 : 1
m37*m75937*0.1
nodelay
--
0
PMID: 18650913 After activation by intracellular Ca2+ ions, cytosolic phospholipase A2 generates arachidonic acid and lysophosphatidic acid, the precursors of the two classes of lipid mediator listed above, from phosphatidylcholine.
p22
p22
cso30:i:ME_UnknownProduction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c63 : 1
stoichiometry:c61 : 1
m37*m75937*0.1
nodelay
--
0
PMID: 18650913 After activation by intracellular Ca2+ ions, cytosolic phospholipase A2 generates arachidonic acid and lysophosphatidic acid, the precursors of the two classes of lipid mediator listed above, from phosphatidylcholine.
p23
p23
cso30:i:ME_MetabolicReaction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c66 : 1
stoichiometry:c65 : 1
stoichiometry:c71 : 1
m349736*m3590*0.1
nodelay
--
0
PMID: 18650913 Arachidonic acid is metabolized to form eicosanoids either by cyclooxygenases (COX1 and COX2), which generate prostaglandins and thromboxanes, or by lipoxygenases, which generate leukotrienes and lipoxins.
p24
p24
cso30:i:ME_MetabolicReaction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c69 : 1
stoichiometry:c70 : 1
m349736*m5784*0.1
nodelay
--
0
PMID: 18650913 Arachidonic acid is metabolized to form eicosanoids either by cyclooxygenases (COX1 and COX2), which generate prostaglandins and thromboxanes, or by lipoxygenases, which generate leukotrienes and lipoxins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m38*0.1
nodelay
--
0
PMID: 18650913 The second class of lipid mediator, platelet-activating factors, are generated by the acetylation of lysophosphatidic acid and activate several processes that occur during the inflammatory response, including recruitment of leukocytes, vasodilation and vasoconstriction, increased vascular permeability and platelet activation.
p26
p26
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m3826*m41*0.1
nodelay
--
0
PMID: 18650913 Seventh, several proteolytic enzymes (including elastin, cathepsins and matrix metalloproteinases) have diverse roles in inflammation, in part through degrading ECM and basement-membrane proteins.
p27
p27
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m35573*m41*0.1
nodelay
--
0
PMID: 18650913 Seventh, several proteolytic enzymes (including elastin, cathepsins and matrix metalloproteinases) have diverse roles in inflammation, in part through degrading ECM and basement-membrane proteins.
p28
p28
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m7190*m41*0.1
nodelay
--
0
PMID: 18650913 Seventh, several proteolytic enzymes (including elastin, cathepsins and matrix metalloproteinases) have diverse roles in inflammation, in part through degrading ECM and basement-membrane proteins.
PMID: 18650913 These proteases have important roles in many processes, including host defence, tissue remodelling and leukocyte migration.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m33*0.1
nodelay
--
0
PMID: 18650913 The Hageman factor activates the kallikrein?kinin cascade, and the main product of this cascade, bradykinin, affects the vasculature, as well as having a potent pro-algesic (pain-stimulating) effect.
PMID: 18650913 These proteases have important roles in many processes, including host defence, tissue remodelling and leukocyte migration.
PMID: 18650913 These proteases have important roles in many processes, including host defence, tissue remodelling and leukocyte migration.
PMID: 18650913, 11983155 The stress inducible nuclear factor-kappaB pathway inhibits apoptosis by engaging multiple mechanisms.
PMID: 18650913, 16391229, 15145826 The key effectors of apoptosis ¡½ caspase 3, caspase 6 and caspase 7 ¡½ cleave and inactivate PARP (which is involved in DNA repair), thereby blocking PARP-dependent necrosis36 (which results from the depletion of cytosolic NAD, a substrate of PARP.
p34
p34
cso30:i:ME_ProteinCleavage
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c95 : 1
stoichiometry:c89 : 1
m2965*m2381*0.1
nodelay
--
0
PMID: 18650913, 16391229, 15145826 The key effectors of apoptosis ¡½ caspase 3, caspase 6 and caspase 7 ¡½ cleave and inactivate PARP (which is involved in DNA repair), thereby blocking PARP-dependent necrosis36 (which results from the depletion of cytosolic NAD, a substrate of PARP.
p35
p35
cso30:i:ME_ProteinCleavage
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c94 : 1
stoichiometry:c91 : 1
m2965*m1765*0.1
nodelay
--
0
PMID: 18650913, 16391229, 15145826 The key effectors of apoptosis ¡½ caspase 3, caspase 6 and caspase 7 ¡½ cleave and inactivate PARP (which is involved in DNA repair), thereby blocking PARP-dependent necrosis36 (which results from the depletion of cytosolic NAD, a substrate of PARP.
p36
p36
cso30:i:ME_ProteinCleavage
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c96 : 1
stoichiometry:c93 : 1
m2965*m2382*0.1
nodelay
--
0
PMID: 18650913, 16391229, 15145826 The key effectors of apoptosis ¡½ caspase 3, caspase 6 and caspase 7 ¡½ cleave and inactivate PARP (which is involved in DNA repair), thereby blocking PARP-dependent necrosis36 (which results from the depletion of cytosolic NAD, a substrate of PARP.
p37
p37
cso30:i:ME_UnknownProduction
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
stoichiometry:c101 : 1
stoichiometry:c98 : 1
m2965*0.1
nodelay
--
0
PMID: 18650913, 16391229, 15145826 The key effectors of apoptosis ¡½ caspase 3, caspase 6 and caspase 7 ¡½ cleave and inactivate PARP (which is involved in DNA repair), thereby blocking PARP-dependent necrosis36 (which results from the depletion of cytosolic NAD, a substrate of PARP.
p4
p4
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m12*m11*0.1
nodelay
--
0
PMID: 18650913, 16407890 For example, the pore-forming exotoxins produced by Grampositive bacteria are detected by the NALP3 (NACHT-, leucine-richrepeat and pyrin-domain-containing protein) inflammasome, which is sensitive to the efflux of K+ ions that results from pore formation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m14*m15*0.1
nodelay
--
0
PMID: 18650913, 16407890 ATP binds to purino ceptors (including P2X7) at the surface of macrophages, resulting in K+ ion efflux, and can cooperate with other signals to activate the NALP3 inflammasome.
p6
p6
cso30:i:ME_Translocation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m16*m17*0.1
nodelay
--
0
PMID: 18650913, 16407890 ATP binds to purino ceptors (including P2X7) at the surface of macrophages, resulting in K+ ion efflux, and can cooperate with other signals to activate the NALP3 inflammasome.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c11 : 1
m13*m16*m18*0.1
nodelay
--
0
PMID: 18650913, 16407890 ATP binds to purino ceptors (including P2X7) at the surface of macrophages, resulting in K+ ion efflux, and can cooperate with other signals to activate the NALP3 inflammasome.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c16 : 1
stoichiometry:c15 : 1
m20*m14*0.1
nodelay
--
0
PMID: 18650913, 11557989 ATP also activates nociceptors (which are sensory receptors), thereby reporting tissue injury to the nervous system.
p9
p9
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m44154*m44616*0.1
nodelay
--
0
PMID: 18650913, 16267105, 10399917 HMGB1 and S100A12 engage the receptor RAGE (advanced glycation end-product-specific receptor; also known as AGER), which (atleast in the case of HMGB1) cooperates with TLRs to induce aninflammatory response.
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--